• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Benefits of monitoring plasma levodopa in Parkinson's disease patients with drug-induced chorea.

作者信息

Sage J I, Mark M H, McHale D M, Sonsalla P K, Vitagliano D

机构信息

Department of Neurology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick 08903.

出版信息

Ann Neurol. 1991 Jun;29(6):623-8. doi: 10.1002/ana.410290609.

DOI:10.1002/ana.410290609
PMID:1892365
Abstract

We studied the temporal patterns of chorea and plasma levodopa profiles in 30 patients with Parkinson's disease whose motor fluctuations were difficult to characterize and treat on the basis of observation alone. We were able to determine whether chorea was associated with high levodopa concentrations or low levodopa concentrations or both. We found the following patterns of levodopa-associated chorea: chorea due to inadequate levodopa levels, chorea due to biphasic levodopa absorption, chorea associated with either rapid or slow levodopa absorption, and chorea due to long-duration levodopa absorption mimicking a sustained-release preparation. Seven patients benefited after their dosing schedules were rearranged as a result of information gained from monitoring. We conclude that any patient with levodopa-associated chorea who cannot be regulated on the basis of observation alone should be studied with simultaneous plasma levodopa measurements and clinical monitoring to detect an unusual plasma levodopa pattern that may be improved by adjustment of dosing schedule.

摘要

相似文献

1
Benefits of monitoring plasma levodopa in Parkinson's disease patients with drug-induced chorea.
Ann Neurol. 1991 Jun;29(6):623-8. doi: 10.1002/ana.410290609.
2
Severe evening dyskinesias in advanced Parkinson's disease: clinical description, relation to plasma levodopa, and treatment.晚期帕金森病的严重夜间异动症:临床描述、与血浆左旋多巴的关系及治疗
Mov Disord. 1994 Mar;9(2):173-7. doi: 10.1002/mds.870090208.
3
Drenching sweats as an off phenomenon in Parkinson's disease: treatment and relation to plasma levodopa profile.帕金森病中的大汗淋漓作为一种撤药现象:治疗及其与血浆左旋多巴水平的关系
Ann Neurol. 1995 Jan;37(1):120-2. doi: 10.1002/ana.410370124.
4
Pharmacokinetics of levodopa.左旋多巴的药代动力学。
J Neurol. 2010 Nov;257(Suppl 2):S253-61. doi: 10.1007/s00415-010-5728-8.
5
Pharmacokinetic and pharmacodynamic considerations in management of motor response fluctuations in Parkinson's disease.帕金森病运动反应波动管理中的药代动力学和药效学考量
Neurol Clin. 1990 Feb;8(1):31-49.
6
[The effect of controlled release of DOPA and carbidopa on clinical response and plasma pharmacokinetics of DOPA in parkinsonian patients].[左旋多巴和卡比多巴控释制剂对帕金森病患者临床反应及左旋多巴血浆药代动力学的影响]
Neurologia. 1997 Apr;12(4):145-56.
7
Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.盐酸多奈哌齐与左旋多巴/卡比多巴联合用于帕金森病患者:多次口服给药后药代动力学变化及安全性评估
Br J Clin Pharmacol. 2004 Nov;58 Suppl 1(Suppl 1):41-9. doi: 10.1111/j.1365-2125.2004.01799.x.
8
Pharmacokinetics and bioavailability of Sinemet CR: a summary of human studies.息宁控释片的药代动力学和生物利用度:人体研究综述
Neurology. 1989 Nov;39(11 Suppl 2):25-38.
9
The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport.帕金森病中的“开-关”现象。与左旋多巴吸收和转运的关系。
N Engl J Med. 1984 Feb 23;310(8):483-8. doi: 10.1056/NEJM198402233100802.
10
Controlled-release carbidopa/levodopa (CR) in parkinsonian patients with response fluctuations on standard levodopa treatment: clinical and pharmacokinetic observations.接受标准左旋多巴治疗出现反应波动的帕金森病患者使用控释卡比多巴/左旋多巴(CR):临床及药代动力学观察
Neurology. 1989 Nov;39(11 Suppl 2):88-92; discussion 95.

引用本文的文献

1
Periodic Limb Movements while Awake () as a Manifestation of Wearing-Off in Parkinson's Disease: A Case Series and Review of the Literature.清醒期周期性肢体运动(PLMA)作为帕金森病剂末现象的一种表现:病例系列及文献综述
Mov Disord Clin Pract. 2022 Jun 10;9(5):652-658. doi: 10.1002/mdc3.13487. eCollection 2022 Jul.
2
Wearable Electrochemical Sensors in Parkinson's Disease.可穿戴电化学传感器在帕金森病中的应用。
Sensors (Basel). 2022 Jan 26;22(3):951. doi: 10.3390/s22030951.
3
Drug-induced movement disorders.药物性运动障碍
Drug Saf. 1997 Mar;16(3):180-204. doi: 10.2165/00002018-199716030-00004.
4
Pharmacokinetic optimisation in the treatment of Parkinson's disease.帕金森病治疗中的药代动力学优化
Clin Pharmacokinet. 1996 Jun;30(6):463-81. doi: 10.2165/00003088-199630060-00004.